Medications starting with
Spain-
It is used to treat certain kidney tumors (renal angiomyolipomas) and brain tumors (SEGA) in adults and children, caused by a genetic disorder called tuberous sclerosis complex (TSC).
Dosage form: tablets
Active substance Dosage everolimus 10,00 mg Manufacturer: Novartis Europharm Limited
-
It is used to treat certain kidney tumors (renal angiomyolipomas) and brain tumors (subependymal giant cell astrocytomas or SEGA) in adults and children, caused by a genetic disorder called tuberous sclerosis complex (TSC).
Dosage form: tablets, dispersible
Active substance Dosage everolimus 2 mg Manufacturer: Novartis Europharm Limited
-
It is used to treat kidney tumors (renal angiomyolipomas) and brain tumors (subependymal giant cell astrocytomas or SEGA) in people with a genetic disorder called tuberous sclerosis complex (TSC).
Dosage form: tablets
Active substance Dosage everolimus 2,5 mg Manufacturer: Novartis Europharm Limited
-
It is used to treat kidney tumors (renal angiomyolipomas) and brain tumors (subependymal giant cell astrocytomas or SEGA) in adults and children, caused by a genetic disorder called tuberous sclerosis complex (TSC).
Dosage form: tablets, dispersible
Active substance Dosage everolimus 3 mg Manufacturer: Novartis Europharm Limited
-
It is used to treat certain kidney tumors (renal angiomyolipomas) and brain tumors (subependymal giant cell astrocytomas or SEGA) in adults and children, caused by a genetic disorder called tuberous sclerosis complex (TSC).
Dosage form: tablets, dispersible
Active substance Dosage everolimus 5 mg Manufacturer: Novartis Europharm Limited
-
It is used to treat kidney tumors (renal angiomyolipomas) and brain tumors (SEGA) in adults and children who have a genetic disorder called tuberous sclerosis complex (TSC).
Dosage form: tablets
Active substance Dosage everolimus 5 mg Manufacturer: Novartis Europharm Limited
-
It is used to treat achondroplasia in patients from 4 months of age and older whose bones are still growing. This is a genetic disease that affects the growth of almost all the bones in the body.
Dosage form: powder and solution for injection
Active substance Dosage vosoritide 0,4 mg Manufacturer: Biomarin International Limited
-
It is used to treat achondroplasia in patients from 4 months of age and older whose bones are still growing. This genetic disease affects the growth of almost all the bones in the body.
Dosage form: powder and solution for injection
Active substance Dosage vosoritide 0,56 mg Manufacturer: Biomarin International Limited
-
It is used to treat achondroplasia in patients aged 4 months or older whose bones are still growing. This genetic disease affects the growth of nearly all the bones in the body.
Dosage form: powder and solution for injection
Active substance Dosage vosoritide 1,2 mg Manufacturer: Biomarin International Limited
-
It is used to treat adult patients with paroxysmal nocturnal hemoglobinuria (PNH) who are already receiving treatment with C5 inhibitors (ravulizumab or eculizumab) and who present with residual hemolytic anemia.
Dosage form: tablets, film-coated
Active substance Dosage danicopan 100 mg Manufacturer: Alexion Europe Sas
-
It is used to treat adult patients with paroxysmal nocturnal hemoglobinuria (PNH) who are already receiving treatment with C5 inhibitors (ravulizumab or eculizumab) and who still present with residual hemolytic anemia.
Dosage form: tablets, film-coated
Active substance Dosage danicopan 50 mg danicopan 100 mg Manufacturer: Alexion Europe Sas
-
It is used as long-term enzyme replacement therapy for patients with type 1 Gaucher disease.
Dosage form: powder for solution for infusion
Active substance Dosage velaglucerase alfa 400 U Manufacturer: Takeda Pharmaceuticals International Ag Ireland Branch
-
It is a contrast medium used to improve the quality of images obtained during magnetic resonance imaging (MRI) scans. It helps to better visualize certain structures or lesions and to differentiate healthy tissue from diseased tissue.
Dosage form: solution for injection
Active substance Dosage gadopiclenol 485,1 mg Manufacturer: Bracco Imaging S.P.A.
-
It is used to treat relapsing-remitting multiple sclerosis (RRMS) in adults.
Dosage form: capsules, hard, enteric-coated
Active substance Dosage diroximel fumarate 231 mg Manufacturer: Biogen Netherlands B.V.
-
It is used in adults to treat migraine attacks once they have started and to prevent these attacks from occurring.
Dosage form: powder for preparation of oral solution
Active substance Dosage rimegepant sulfate 85,65 mg Manufacturer: Pfizer Europe Ma Eeig
-
It is used to prevent migraine in adults who suffer from attacks at least 4 days per month.
Dosage form: solution for infusion, concentrate and solvent
Active substance Dosage eptinezumab 100 mg Manufacturer: H. Lundbeck A/S
-
It is used to treat transthyretin amyloidosis in adult patients with heart involvement (symptomatic cardiomyopathy). It helps prevent the TTR protein from breaking down and forming amyloid.
Dosage form: capsules, soft gelatin
Active substance Dosage taflamidis 61 mg Manufacturer: Pfizer Europe Ma Eeig
-
It is used to treat transthyretin amyloidosis in adults with nerve involvement, in order to delay the progression of the disease.
Dosage form: capsules, soft gelatin
Active substance Dosage tafamidis meglumine 20 mg Manufacturer: Pfizer Europe Ma Eeig
-
It is used to treat postmenopausal osteoporosis in women and bone loss in men at risk of fracture. It is also used to treat bone loss caused by testosterone reduction in patients with prostate cancer or bone loss due to long-term glucocorticoid treatment.
Dosage form: solution for injection
Active substance Dosage denosumab 60 mg Manufacturer: Intas Third Party Sales 2005 S.L.
-
It is used to reduce levels of total cholesterol, 'bad' cholesterol (LDL), and triglycerides in the blood, as well as to increase 'good' cholesterol (HDL). It is prescribed in patients who cannot control their cholesterol through diet alone or who have heart disease to reduce the risk of heart attack or stroke.
Dosage form: tablets
Active substance Dosage ezetimibe 10 mg simvastatin 20 mg Manufacturer: Organon Salud S.L.
-
It is used to reduce levels of total cholesterol, 'bad' cholesterol (LDL), and triglycerides in the blood, as well as to increase 'good' cholesterol (HDL). It is prescribed in patients who cannot control their cholesterol through diet alone or who have heart disease to reduce the risk of heart attack or stroke.
Dosage form: tablets
Active substance Dosage ezetimibe 10 mg simvastatin 40 mg Manufacturer: Organon Salud S.L.
-
It is used in adults to treat generalized myasthenia gravis (gMG), an autoimmune disease that causes muscle weakness, and chronic inflammatory demyelinating polyneuropathy (CIDP), which causes weakness or numbness in the arms and legs.
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage efgartigimod alfa 1000 mg Manufacturer: Argenx B.V.
-
It is used to treat adults with generalized myasthenia gravis (gMG), a disease that causes muscle weakness, and also to treat chronic inflammatory demyelinating polyneuropathy (CIDP), which causes weakness or numbness in the arms and legs.
Dosage form: solution for injection
Active substance Dosage efgartigimod alfa 1000 mg Manufacturer: Argenx B.V.
-
It is used in adults with generalized myasthenia gravis (gMG), an autoimmune disease that causes muscle weakness, extreme fatigue, difficulty swallowing, or shortness of breath, to help improve muscle contraction capacity.
Dosage form: solution for infusion, concentrate
Active substance Dosage efgartigimod alfa 20 mg/ml Manufacturer: Argenx B.V.
-
It is used to treat newly diagnosed acute myeloid leukemia, including cases caused by previous treatments or with certain changes in the bone marrow.
Dosage form: powder for concentrate for solution for infusion
Active substance Dosage daunorubicin hydrochloride 44 mg cytarabine 100 mg Manufacturer: Jazz Pharmaceuticals Ireland Limited